Author:
Schalm Solko W.,Brouwer J. T.,Chemello L.,Alberti A.,Bellobuono A.,Ideo G.,Schwartz R.,Weiland O.
Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology,Physiology
Reference8 articles.
1. Brouwer JT, Kleter GEM, Nevens F, Elewaut A, Adler M, Brenard R, Chamuleau RAF, Michielsen P, Pirotte J, Hautekeete ML, Arendt V, Schalm SW: Efficacy of interferon dose and factors predictive of response in chronic hepatitis C: Final results of a Benelux multicentre study. J Hepatol 23(suppl 1):84, 1995
2. Brouwer JT, Kleter GEM, Quint WVG, Heijtink RA, Schalm SW, and the Benelus Study Group on Hepatitis C Treatment: Improved endpoint determination of interferon treatment in hepatitis C by monitoring HCV-RNA. J Hepatol 49:S15, 1991
3. Reichard O, Andersson J, Schvarcz R, Weiland O: Ribavirin treatment for chronic hepatitis C. Lancet 337:1058–1061, 1991
4. Brillanti S, Garson J, Foli M, Whitby K, Deaville R, Masci C, Miglioli M, Barbara L: A pilot study of combination therapy with ribavirin plus interferon alpha for alpha-interferon resistant chronic hepatitis C. Gastroenterology 107:812–817, 1994
5. Brouwer JT, Nevens F, Michielsen P, Hautekeete ML, Chamuleau RAF, Adler M, Delweide J, Heijtink RA, Schalm SW: What options are left when hepatitis C does not respond to interferon? Placebo-controlled Benelux multicentre trial on ribavirin mono-therapy versus prolonged combination with interferon. J Hepatol 21:S17, 1994
Cited by
25 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献